NOD2

Emma M Dangerfield1,2, Shigenari Ishizuka3,4, Kristel Kodar1,2

  • 1School of Chemical and Physical Sciences, Victoria University of Wellington, PO Box 600, Wellington 6140, New Zealand.

PubMed
概括

针对Mincle和NOD2受体的新型嵌合体疫苗辅助剂显示出有前途. 这些结合物增强T细胞免疫反应并降低毒性,与当前的辅助策略相比,提供了潜在的改善.